Novo Nordisk pops after Ozempic beats Lilly’s older drug in heart risk study Novo Nordisk pops after Ozempic beats Lilly’s older drug in heart risk study Post Contentnvo, llyRead More You might also be interested in reading DeFi and TradFi must put aside their differences. September 18, 2025 In Mainstream ← Previous post Next post →